Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…

Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …

Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …

Objective To compare the effectiveness of a primary covid-19 vaccine series plus booster
doses with a primary series alone for the prevention of hospital admission with omicron related …

Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination coverage increases in the United States, there is a need to understand the real-world …

Objectives To characterize the clinical severity of COVID-19 caused by Omicron, Delta, and
Alpha SARS-CoV-2 variants among hospitalized adults and to compare the effectiveness of …

Introduction Understanding the changing epidemiology of adults hospitalized with coronavirus
disease 2019 (COVID-19) informs research priorities and public health policies. Methods …

Background The study objective was to evaluate 2- and 3-dose coronavirus disease 2019 (COVID-19)
mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among …

Background During the COVID‐19 pandemic, self‐reported COVID‐19 vaccination might
facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (eg, …

Vaccine effectiveness (VE) against COVID-19 hospitalization was evaluated among
immunocompetent adults (≥18 years) during March–August 2021 using a case-control design. …